DE3867563D1 - 2-amino-5-hydroxy-4-pyrimidone. - Google Patents

2-amino-5-hydroxy-4-pyrimidone.

Info

Publication number
DE3867563D1
DE3867563D1 DE8888306000T DE3867563T DE3867563D1 DE 3867563 D1 DE3867563 D1 DE 3867563D1 DE 8888306000 T DE8888306000 T DE 8888306000T DE 3867563 T DE3867563 T DE 3867563T DE 3867563 D1 DE3867563 D1 DE 3867563D1
Authority
DE
Germany
Prior art keywords
alkyl
hydroxy
amino
pyrimidone
substd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888306000T
Other languages
German (de)
English (en)
Inventor
Frederick Judson Walker
Brian Thomas O'neill
John Lawrence Lamattina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3867563D1 publication Critical patent/DE3867563D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Hydrogenated Pyridines (AREA)
DE8888306000T 1987-07-09 1988-07-01 2-amino-5-hydroxy-4-pyrimidone. Expired - Lifetime DE3867563D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001608 WO1989000423A1 (en) 1987-07-09 1987-07-09 2-amino-5-hydroxy-4-pyrimidones

Publications (1)

Publication Number Publication Date
DE3867563D1 true DE3867563D1 (en) 1992-02-20

Family

ID=22202454

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888306000T Expired - Lifetime DE3867563D1 (en) 1987-07-09 1988-07-01 2-amino-5-hydroxy-4-pyrimidone.

Country Status (12)

Country Link
EP (1) EP0303348B1 (Direct)
JP (1) JPH0629264B2 (Direct)
AT (1) ATE71370T1 (Direct)
CA (1) CA1310642C (Direct)
DE (1) DE3867563D1 (Direct)
DK (1) DK381188A (Direct)
ES (1) ES2037833T3 (Direct)
FI (1) FI883285A7 (Direct)
GR (1) GR3003908T3 (Direct)
IE (1) IE60210B1 (Direct)
PT (1) PT87944B (Direct)
WO (1) WO1989000423A1 (Direct)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111705D0 (en) * 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
US9221809B2 (en) 2011-10-31 2015-12-29 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
AP2014007637A0 (en) 2011-11-15 2014-05-31 Takeda Pharmaceutical Dihydroxy aromatic heterocyclic compound
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
WO2020163689A1 (en) 2019-02-08 2020-08-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education 20-hete formation inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756189A (en) 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
US4153793A (en) * 1973-05-03 1979-05-08 Smith Kline & French Laboratories Limited Imidazo alkylamino pyrimidones
IN153791B (Direct) * 1979-03-10 1984-08-18 Soc D Etudes Prod Chimique
FR2503162A1 (fr) 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
GB8421427D0 (en) 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
DE3436380A1 (de) * 1984-10-04 1986-04-10 Bayer Ag, 5090 Leverkusen Selektiv-fungizide mittel auf pyrimidin-derivat-basis
JPS61205260A (ja) * 1985-03-08 1986-09-11 Zeria Shinyaku Kogyo Kk 新規な２−置換アミノ−６−（２−メトキシフエニ−ル）−４（３ｈ）−ピリミドン誘導体及びその製造法

Also Published As

Publication number Publication date
PT87944B (pt) 1995-03-01
CA1310642C (en) 1992-11-24
JPH0629264B2 (ja) 1994-04-20
IE60210B1 (en) 1994-06-15
GR3003908T3 (Direct) 1993-03-16
ATE71370T1 (de) 1992-01-15
FI883285A7 (fi) 1989-01-10
EP0303348B1 (en) 1992-01-08
JPS6429367A (en) 1989-01-31
DK381188D0 (da) 1988-07-08
DK381188A (da) 1989-02-21
IE882107L (en) 1989-01-09
WO1989000423A1 (en) 1989-01-26
ES2037833T3 (es) 1993-07-01
FI883285A0 (fi) 1988-07-08
EP0303348A1 (en) 1989-02-15
PT87944A (pt) 1989-06-30

Similar Documents

Publication Publication Date Title
AU3317495A (en) Aroyl-piperidine derivatives
AU635779B2 (en) 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
DE3882544D1 (de) Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
NO954139D0 (no) Kinoksaliner, deres fremstilling og anvendelse
ES8602649A1 (es) Procedimiento para preparar 4-hidroximetil-pirrolidinonas substituidas en posicion 1
HU9503592D0 (en) Use of 5-acyl-1,4-dihydropyridines
FI893901A0 (fi) Menetelmä tetrasyklisten masennuslääkkeiden valmistamiseksi
AU638791B2 (en) Substituted dioxolane, and diol derivatives
DE3864193D1 (de) Substituierte 5-amino-pyrazole und diese enthaltende fungizide.
ES8604505A1 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquilsulfonilfenil)-2-amino-1,3-propandiol n-substituidos
ES8604118A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido
DK313388D0 (da) 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-oe1aabenzothienooe3,2-eaa-1,2-thiazin-4-carboxamid-1,1-dioxid-forbindelser, farmaceutiske praeparater indeholdende disse og forbindelser til anvendelse som udgangsmateriale ved deres fremstilling
HU9503597D0 (en) Use of 1,2-alkylene-1,4-dihydro-pyridine derivatives as medicine
ATE192155T1 (de) Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ES8506310A1 (es) N-oxidos de derivados aminociclicos
DK656389A (da) Phenyl-triazol-pyrimidin-derivat og dets anvendelse som laegemiddel
ES8800141A1 (es) Un procedimiento para preparar un derivado de semicarbazida
IT1230754B (it) Camposti con attivita' analgesica centrale.
CS641988A2 (en) Method of 1,4-dihydropyridines production

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee